⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KNSA News
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London
globenewswire.com
KNSA
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
globenewswire.com
KNSA
Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025
globenewswire.com
KNSA
Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis
globenewswire.com
KNSA